Cipla (CIPLA) — Announcement

Cipla Limited has entered into definitive agreements to acquire 100% stake in Inzpera Healthsciences Limited for approximately ₹110.65 crores in an all-cash transaction. Inzpera, incorporated in 2016, develops and markets differentiated paediatric pharmaceutical and wellness products with FY2024-25 turnover of ₹26.75 crores. The acquisition is strategic, leveraging Inzpera's product portfolio with Cipla's distribution network and operational capabilities. Completion is expected within one month. The transaction is not a related-party deal and requires no regulatory approvals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this announcement affect Cipla Limited's outlook?" "What did Cipla Limited announce on 3 November 2025?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 3 November 2025

BEL Bharat Electronics Limited Financial Results ULTRACEMCO UltraTech Cement Limited Corporate Action AMBUJACEM Ambuja Cements Limited Financial Results BAJAJFINSV Bajaj Finserv Limited Financial Results AMBUJACEM Ambuja Cements Limited Financial Results BHARTIARTL Bharti Airtel Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.